Please use this identifier to cite or link to this item: https://doi.org/10.1155/2015/219012
Title: Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?
Authors: Wong, A 
Ngeow, J 
Keywords: BRCA1 protein
BRCA2 protein
cancer epidemiology
cancer patient
cancer risk
Cowden syndrome
endometrium carcinoma
female
gene
gene mutation
hereditary nonpolyposis colorectal cancer
human
immunohistochemistry
laboratory test
meta analysis (topic)
mismatch repair
Muir Torre syndrome
multicenter study (topic)
mutational analysis
oncogene
ovary carcinoma
polymerase chain reaction
PTEN gene
Review
risk assessment
Colorectal Neoplasms, Hereditary Nonpolyposis
Endometrial Neoplasms
Hamartoma Syndrome, Multiple
Muir-Torre Syndrome
pathology
risk assessment
Colorectal Neoplasms, Hereditary Nonpolyposis
DNA Mismatch Repair
Endometrial Neoplasms
Female
Hamartoma Syndrome, Multiple
Humans
Muir-Torre Syndrome
Risk Assessment
Issue Date: 2015
Citation: Wong, A, Ngeow, J (2015). Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?. BioMed Research International 2015 : 219012. ScholarBank@NUS Repository. https://doi.org/10.1155/2015/219012
Rights: Attribution 4.0 International
Abstract: Endometrial carcinoma is the most common gynecological tumor worldwide. It can be the presenting malignancy, acting as the harbinger, of an undiagnosed hereditary syndrome. Up to 50% of females with Lynch syndrome present in this manner. Differentiation between Lynch, Muir-Torre, and Cowden syndromes can at times be challenging due to the overlapping features. Our review emphasizes on the strengths, pitfalls, and limitations of microscopic features as well as immunohistochemical and polymerase chain reaction- (PCR-) based tests used by laboratories to screen for DNA mismatch repair (MMR) and PTEN gene mutations in patients to enable a more targeted and cost effective approach in the use of confirmatory gene mutational analysis tests. This is crucial towards initiating timely and appropriate surveillance measures for the patient and affected family members. We also review the evidence postulating on the possible inclusion of uterine serous carcinoma as part of the spectrum of malignancies seen in hereditary breast and ovarian carcinoma syndrome, driven by mutations in BRCA1/2. © 2015 Adele Wong and Joanne Ngeow.
Source Title: BioMed Research International
URI: https://scholarbank.nus.edu.sg/handle/10635/183610
ISSN: 23146133
DOI: 10.1155/2015/219012
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1155_2015_219012.pdf1.39 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

13
checked on Apr 19, 2021

Page view(s)

37
checked on Apr 15, 2021

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons